Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma [PDF]
Background Formoterol is a long-acting beta(2)-agonist but because it has a fast onset of action it can also be used as a relief medication. Objectives To asses the efficacy and safety of formoterol as reliever therapy in comparison to short-acting ...
Cates, CJ, Welsh, EJ
core +1 more source
Evaluating Patient Preferences of Maintenance Therapy for the Treatment of Chronic Obstructive Pulmonary Disease: A Discrete Choice Experiment in the UK, USA and Germany. [PDF]
Introduction: With increasing availability of different treatments for chronic obstructive pulmonary disease (COPD), we sought to understand patient preferences for COPD treatment in the UK, USA, and Germany using a discrete choice experiment (DCE ...
Doll, HA +7 more
core +1 more source
Objective: The objective was to assess the inhalational techniques and its common errors in bronchial asthma patients. Methodology: This cross-sectional study was conducted from July 2019 to September 2019. All known asthmatic patients on inhaler therapy
Shivani Dalal +2 more
doaj +1 more source
Regular treatment with formoterol for chronic asthma: serious adverse events [PDF]
Epidemiological evidence has suggested a link between beta(2)-agonists and increases in asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta2-agonists are safe ...
Altman +17 more
core +1 more source
Asthma and chronic obstructive pulmonary disease (COPD) are chronic airway disorders. The patients must receive suitable management to control progression and prevent disease exacerbation.
Karnchanok Maliphan +3 more
doaj
Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis. [PDF]
BACKGROUND: Pharmacological therapy for chronic obstructive pulmonary disease (COPD) is aimed at relieving symptoms, improving quality of life and preventing or treating exacerbations.Treatment tends to begin with one inhaler, and additional therapies ...
Aalbers +511 more
core +1 more source
Development of dry powder inhaler containing tadalafil-loaded PLGA nanoparticles
Inhalable dry powders containing poly lactic-co-glycolic acid (PLGA) nanoparticles (NPs) were developed for the delivery of tadalafil (TAD) for treatment of life-treating pulmonary arterial hypertension.
Jaleh Varshosaz +4 more
doaj +1 more source
Multivariate data analysis to assess dry powder inhalers performance from powder properties [PDF]
The study aimed at investigating the correlations among the physical and bulk properties of carrier based dry powder inhaler formulations and the performance of the powder inhaler device estimated by in-vitro tests for a specific active pharmaceutical ...
Bosi, Roberto +6 more
core +1 more source
Cardiac safety of tiotropium in patients with cardiac events: a retrospective analysis of the UPLIFT® trial. [PDF]
BackgroundTiotropium is an anticholinergic bronchodilator for symptom relief and reducing exacerbations with an established safety profile in patients with chronic obstructive pulmonary disease (COPD).
Decramer, Marc +3 more
core +1 more source
Objective: To demonstrate the most frequent errors in inhalation technique in patients with asthma undergoing treatment at a tertiary care hospital. Methods: A cross-sectional study with a convenience sample of asthma patients aged 18 years or over ...
Carlos Leonardo Carvalho Pessôa +7 more
doaj +1 more source

